π΅οΈ American Healthcare REIT, Inc. ($AHR)
SEC insider & ownership activity, last 12 months Β· CIK 1632970 Β· every row links its SEC filing
Over the last 12 months insiders sold $5.5M with no open-market buying against it. Jeffrey Hanson sold $3.6M in discretionary trades (NovβDec). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) Β· 3 sellers, $5.5M (9 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Jeffrey Hanson | 0 | β | 3 | $3.6M | Dec 23, 2025 |
| Peay Brian | 0 | β | 1 | $1.3M | Jun 26, 2026 |
| Mark E. Foster | 0 | β | 5 | $550K | Jun 24, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 11.5% | 13G | Jul 27, 2026 | filing β | |
| Vanguard Portfolio Management | 8.6% | 13G | Apr 28, 2026 | filing β | |
| Principal Real Estate Investors, LLC | 7.7% | 13G | Feb 10, 2025 | filing β | |
| Wellington Management Company LLP | 5.9% | 13G | Feb 10, 2025 | filing β | |
| Vanguard Capital Management | 5.1% | 13G | Apr 29, 2026 | filing β | |
| State Street Corporation | 5.1% | 13G | May 12, 2026 | filing β |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Brian Peay | $1.3M | Jun 26, 2026 | filing β |
| Mark Foster | $121K | Jun 24, 2026 | filing β |
| Mark Foster | $97K | Jun 1, 2026 | filing β |
| Mark Foster | $97K | Mar 25, 2026 | filing β |
| Jeffrey Hanson | $2.6M | Dec 22, 2025 | filing β |
| Mark Foster | $74K | Nov 11, 2025 | filing β |
| Jeffrey Hanson | $994K | Nov 10, 2025 | filing β |
| Mark E. Foster | $161K | Sep 3, 2025 | filing β |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 20, 2026 | filing β |
| Reg FD disclosure (7.01) | Jul 20, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jul 20, 2026 | filing β |
| Shareholder vote (5.07) | Jun 24, 2026 | filing β |
| Reg FD disclosure (7.01) | Jun 18, 2026 | filing β |
| Other events (8.01) | Jun 18, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jun 18, 2026 | filing β |
| Other events (8.01) | May 26, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 26, 2026 | filing β |
| Other events (8.01) | May 20, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 20, 2026 | filing β |
| Earnings (2.02) | May 7, 2026 | filing β |
| Reg FD disclosure (7.01) | May 7, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing β |
| Material agreement (1.01) | Apr 1, 2026 | filing β |
| New financial obligation (2.03) | Apr 1, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Apr 1, 2026 | filing β |
| Reg FD disclosure (7.01) | Mar 18, 2026 | filing β |
| Other events (8.01) | Mar 18, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Mar 18, 2026 | filing β |
| Material agreement (1.01) | Feb 27, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 27, 2026 | filing β |
| Earnings (2.02) | Feb 26, 2026 | filing β |
| Reg FD disclosure (7.01) | Feb 26, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing β |
| Officer/director changes (5.02) | Feb 3, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 3, 2026 | filing β |
| Officer/director changes (5.02) | Feb 3, 2026 | filing β |
| Reg FD disclosure (7.01) | Feb 3, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 3, 2026 | filing β |